Back to Search
ERIC SIEVERS, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1659640944Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD00027494(WA)G165772(CA)
Research & Publications (20)
Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.
PMID 15942563·J Thorac Cardiovasc Surg·2005
7-preclinical
Native antibody and antibody-targeted chemotherapy for acute myeloid leukemia.
PMID 15464909·Adv Pharmacol·2004
6-review
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.
PMID 12506020·Blood·2003
8-other
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.
PMID 11432892·J Clin Oncol·2001
3-trial
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse.
PMID 11728223·Expert Opin Biol Ther·2001
6-review
Clinical studies of new "biologic" approaches to therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.
PMID 10687726·Curr Opin Oncol·2000
6-review
Detection of minimal residual disease in acute leukemia.
PMID 10882176·Curr Opin Hematol·2000
6-review
Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.
PMID 10950142·Cancer Chemother Pharmacol·2000
6-review
Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia.
PMID 10685657·Cancer J Sci Am·2000
3-trial
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Endothelial and virgultar cell formations in the mammalian lymph node sinus: endothelial differentiation morphotypes characterized by a special kind of junction (complexus adhaerens).
PMID 19015886·Cell Tissue Res·2009
6-review
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
PMID 19466965·Br J Haematol·2009
3-trial
Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids.
PMID 19546834·Pancreas·2009
7-preclinical
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
PMID 18537185·Hepatology·2008
7-preclinical
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma.
PMID 18347008·J Clin Oncol·2008
3-trial
[Public opinion on breast-feeding and infant nutrition: results of a questionnaire in North Rhine-Westphalia].
PMID 18368647·Gesundheitswesen·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11085 TORREYANA RD
SAN DIEGO, CA 92121 - Phone
- (858) 558-0708
Quick Facts
- NPI
- 1659640944
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile